Skip to main content
. 2021 Feb 19;15(2):e0009128. doi: 10.1371/journal.pntd.0009128

Fig 3. Survival analysis according to Acute Physiology and Chronic Health Evaluation (APACHE) II scores among patients with severe fever with thrombocytopenia syndrome (SFTS).

Fig 3

(A) Kaplan–Meier 30-day survival analysis after admission of patients with severe fever with thrombocytopenia syndrome (SFTS) with and without steroid therapy according to SFTS severity before propensity score matchinga. (B) Kaplan–Meier 30-day survival analysis of patients with severe fever with thrombocytopenia syndrome (SFTS) with and without steroid therapy according to SFTS severity after propensity score matchingb. a. Twenty-two patients had missing data on the initial APACHE II score or 30-day survival time. b. Four patients had missing data on 30-day survival time.